Neuroprotection for Parkinson's disease: prospects and promises

Ann Neurol. 2003:53 Suppl 3:S1-2. doi: 10.1002/ana.10566.
No abstract available

MeSH terms

  • Amphetamines / therapeutic use*
  • Clinical Trials as Topic
  • Glial Cell Line-Derived Neurotrophic Factor
  • Humans
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Nerve Growth Factors / therapeutic use*
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Selegiline / therapeutic use*

Substances

  • Amphetamines
  • GDNF protein, human
  • Glial Cell Line-Derived Neurotrophic Factor
  • Monoamine Oxidase Inhibitors
  • Nerve Growth Factors
  • Neuroprotective Agents
  • Selegiline
  • desmethylselegiline